ConductScience.org, home

Paper41327481

MicroRNA-29b-3p promotes endothelial cell inflammation via NTRK2/PI3K/NLRP3 pathway in Moyamoya disease.

Wei L and 9 others. Eur J Med Res, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. MicroRNA-29b-3p promotes endothelial cell inflammation via NTRK2/PI3K/NLRP3 pathway in Moyamoya disease. Papers, record 41327481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41327481

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
MicroRNA-29b-3p promotes endothelial cell inflammation via NTRK2/PI3K/NLRP3 pathway in Moyamoya disease.
PubMed
Journal
Eur J Med Res
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-01-27
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wei LLiangzhe
2Ren HHe
3Lin YYuanwei
4Deng XXinpeng
5Liu YYuchun
6Zeng JJingjing
7Lin JJinghui
8Gao XXiang
9Sun JJie
10Huang YYi

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MicroRNAsMajor topic
Moyamoya DiseaseMajor topic
Endothelial CellsMajor topic
NLR Family, Pyrin Domain-Containing 3 ProteinMajor topic
Phosphatidylinositol 3-KinasesMajor topic
InflammationMajor topic
Receptor, trkBMajor topic
Humans
Signal Transduction
Membrane Glycoproteins

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2024C03281(SD2)The Key Research and Development Program of Zhejiang ProvincePubMed
2022020304Ningbo Top Medical and Health Research ProgramPubMed
2024L003Ningbo Clinical Research Center for Emergency and Critical DiseasesPubMed

Source PubMed

Download CSV of grants

References60

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135735031Laminar shear stress alleviates monocyte adhesion and atherosclerosis development via miR-29b-3p/CX3CL1 axis regulation.J Cell Sci2022https://conductscience.org/library/papers/35735031PubMed
232165827MicroRNA-29b-3p inhibits cell proliferation and angiogenesis by targeting VEGFA and PDGFB in retinal microvascular endothelial cells.Mol Vis2020https://conductscience.org/library/papers/32165827PubMed
335754359RNF213 loss of function reshapes vascular transcriptome and spliceosome leading to disrupted angiogenesis and aggravated vascular inflammatory responses.J Cereb Blood Flow Metab2022https://conductscience.org/library/papers/35754359PubMed
434279201Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.Curr Neuropharmacol2022https://conductscience.org/library/papers/34279201PubMed
529343587Surgical Management of Moyamoya Disease.Stroke2018https://conductscience.org/library/papers/29343587PubMed
640268337Peripheral blood GATA2 expression impacts RNF213 mutation penetrance and clinical severity in moyamoya disease.Stroke Vasc Neurol2025https://conductscience.org/library/papers/40268337PubMed
726846755Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis.J Stroke2016https://conductscience.org/library/papers/26846755PubMed
832992193Vascular Smooth Muscle Cell Derived from IPS Cell of Moyamoya Disease - Comparative Characterization with Endothelial Cell Transcriptome.J Stroke Cerebrovasc Dis2020https://conductscience.org/library/papers/32992193PubMed
938018829Insights on Moyamoya Disease: Vascular Inflammation and Nuclear Autoschizis in Cranial Arteries.Stroke2024https://conductscience.org/library/papers/38018829PubMed
1014687471Clinical and experimental pathology of Moyamoya disease.Chin Med J (Engl)2003https://conductscience.org/library/papers/14687471PubMed
1135873760TGFβ1 as a Predictive Biomarker for Collateral Formation Within Ischemic Moyamoya Disease.Front Neurol2022https://conductscience.org/library/papers/35873760PubMed
1236497052CircZXDC Promotes Vascular Smooth Muscle Cell Transdifferentiation via Regulating miRNA-125a-3p/ABCC6 in Moyamoya Disease.Cells2022https://conductscience.org/library/papers/36497052PubMed
1335605621Moyamoya disease: diagnosis and interventions.Lancet Neurol2022https://conductscience.org/library/papers/35605621PubMed
1429633884Gelatinolytic activity of autocrine matrix metalloproteinase-9 leads to endothelial de-arrangement in Moyamoya disease.J Cereb Blood Flow Metab2018https://conductscience.org/library/papers/29633884PubMed
1536939771Recent Progresses in Electrochemical DNA Biosensors for MicroRNA Detection.Phenomics2022https://conductscience.org/library/papers/36939771PubMed
1630101479SRPK1 gene silencing promotes vascular smooth muscle cell proliferation and vascular remodeling via inhibition of the PI3K/Akt signaling pathway in a rat model of intracranial aneurysms.CNS Neurosci Ther2019https://conductscience.org/library/papers/30101479PubMed
1735401401Ring Finger Protein 213 in Moyamoya Disease With Pulmonary Arterial Hypertension: A Mini-Review.Front Neurol2022https://conductscience.org/library/papers/35401401PubMed
1833941642Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study.Stroke Vasc Neurol2021https://conductscience.org/library/papers/33941642PubMed
1926180604Epidemiology of Moyamoya Disease in Korea: Based on National Health Insurance Service Data.J Korean Neurosurg Soc2015https://conductscience.org/library/papers/26180604PubMed
20351974022021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society.Neurol Med Chir (Tokyo)2022https://conductscience.org/library/papers/35197402PubMed

See all 60 referencesDownload CSV of references

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IL1B3553PubTator's text mininghttps://conductscience.org/library/genes/3553NCBI Gene
NLRP3114548PubTator's text mininghttps://conductscience.org/library/genes/114548NCBI Gene
NTRK24915PubTator's text mininghttps://conductscience.org/library/genes/4915NCBI Gene
PIK3CB5291PubTator's text mininghttps://conductscience.org/library/genes/5291NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41327481

GET https://conductscience.org/api/papers/v1/41327481/references?page=2